REVANCE THERAPEUTICS INC - COM - Put Institutional Ownership

CUSIP: 761330959

13F Institutional Holders and Ownership History from Q4 2014 to Q1 2025

Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 761330959?
CUSIP 761330959 identifies 761330959 - REVANCE THERAPEUTICS INC - COM - Put in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of REVANCE THERAPEUTICS INC - COM - Put across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0
2024 Q4 $3.04 0
2024 Q3 $5.18 0
2024 Q2 $2.57 0
2024 Q1 $4.92 0
2023 Q4 $8.79 0
2023 Q3 $11.47 0
2023 Q2 $25.31 0
2023 Q1 $32.21 0
2022 Q4 $18.46 0
2022 Q3 $27.00 0
2022 Q2 $13.82 0
2022 Q1 $19.51 0
2021 Q4 $16.29 0
2021 Q3 $28.75 0
2021 Q2 $29.29 0
2021 Q1 $1389.00 0
2020 Q4 $2828.36 0
2020 Q3 $2500.00 0
2020 Q2 $1228.89 0
2020 Q1 $734.71 0
2019 Q4 $1615.38 0
2019 Q3 $1298.08 0
2019 Q2 $1288.46 0
2019 Q1 $1550.00 0
2018 Q4 0
2018 Q3 $1178.89 0
2018 Q2 $1359.79 0
2018 Q1 $86.43 0
2017 Q4 $37.12 0
2016 Q4 0
2016 Q3 $16.00 0
2016 Q2 $64.96 0
2016 Q1 $17.42 0
2015 Q4 $640.49 0
2015 Q3 $1500.00 0
2015 Q2 0
2015 Q1 $20.00 0
2014 Q4 $17.04 0